poisar

Stocks · News reference

Vertex Pharmaceuticals shares are trading higher after the company announced results from a study of its inaxaplin candidate that showed a reduction in urine albumin to creatinine ratio at week 13 and was generally safe and well tolerated.

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

VRTX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?

    Novavax stock jumped 20.1% following renewed investor interest in vaccine stocks, triggered by pneumonia-related concerns in Russia and positive results from Vaxcyte's pneumococcal vaccine. The company benefits from COVID-19 vaccine approvals and a Sanofi partnership. However, Novavax faces declining revenues and continued quarterly losses, though earnings estimate revisions have improved significantly.

    NVAXVRTXPCVX